Divalproex [valproate semisodium] ER [extended release] vs. risperidone for bipolar disorder with comorbid substance use disorder.

Trial Profile

Divalproex [valproate semisodium] ER [extended release] vs. risperidone for bipolar disorder with comorbid substance use disorder.

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 May 2008

At a glance

  • Drugs Risperidone; Valproate semisodium
  • Indications Bipolar disorders; Bipolar I disorders; Bipolar II disorders; Substance-related disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top